Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Imgatuzumab (Synonyms: RO 5083945, RG 7160, Anti-EGFR Recombinant Antibody)

Catalog No. T76811 Copy Product Info
Purity: 95%
🥰Excellent
Imgatuzumab (RG 7160; GA201) is a humanized, glycoengineered IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). This product inhibits EGFR-mediated signaling (such as MAPK and PI3K pathways) by blocking EGF binding and inducing receptor internalization. As a glycoengineered antibody, Imgatuzumab features enhanced affinity for Fc gamma RIIIa, resulting in potent antibody-dependent cellular cytotoxicity (ADCC). It is used to research EGFR-overexpressing solid tumors and demonstrates synergistic effects when combined with chemotherapeutic agents.

Imgatuzumab

Copy Product Info
🥰Excellent
Catalog No. T76811
Synonyms RO 5083945, RG 7160, Anti-EGFR Recombinant Antibody

Imgatuzumab (RG 7160; GA201) is a humanized, glycoengineered IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). This product inhibits EGFR-mediated signaling (such as MAPK and PI3K pathways) by blocking EGF binding and inducing receptor internalization. As a glycoengineered antibody, Imgatuzumab features enhanced affinity for Fc gamma RIIIa, resulting in potent antibody-dependent cellular cytotoxicity (ADCC). It is used to research EGFR-overexpressing solid tumors and demonstrates synergistic effects when combined with chemotherapeutic agents.

Imgatuzumab
Cas No. 959963-46-3
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$247-In Stock
5 mg$747-In Stock
10 mg$1,200-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Imgatuzumab (RG 7160; GA201) is a humanized, glycoengineered IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). This product inhibits EGFR-mediated signaling (such as MAPK and PI3K pathways) by blocking EGF binding and inducing receptor internalization. As a glycoengineered antibody, Imgatuzumab features enhanced affinity for Fc gamma RIIIa, resulting in potent antibody-dependent cellular cytotoxicity (ADCC). It is used to research EGFR-overexpressing solid tumors and demonstrates synergistic effects when combined with chemotherapeutic agents.
In vitro
Imgatuzumab specifically binds EGFR and exhibits potent ADCC activity in A549 and HCT116 cells. Co-treatment with Gemcitabine, Cisplatin, or Paclitaxel, or pretreatment with Dexamethasone, does not impair Imgatuzumab-mediated ADCC; instead, combination therapies enhance overall anti-tumor efficacy [1].
In vivo
Imgatuzumab significantly inhibits tumor growth in lung and colorectal cancer xenograft mouse models. Combination with Gemcitabine or Paclitaxel leads to enhanced tumor regression and prolonged survival compared to monotherapy, demonstrating synergistic anti-tumor efficacy [1].
SynonymsRO 5083945, RG 7160, Anti-EGFR Recombinant Antibody
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetEGFR
Chemical Properties
Molecular Weight145.0 kDa
Cas No.959963-46-3
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Imgatuzumab | purchase Imgatuzumab | Imgatuzumab cost | order Imgatuzumab | Imgatuzumab in vivo | Imgatuzumab in vitro | Imgatuzumab molecular weight